Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common CDKN2A Alteration
Elvin, Julia A., Gay, Laurie M., Ort, Rita, Shuluk, Joseph, Long, Jennifer, Shelley, Lauren, Lee, Ronald, Chalmers, Zachary R., Frampton, Garrett M., Ali, Siraj M., Schrock, Alexa B., Miller, VincentVolume:
22
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2016-0310
Date:
April, 2017
File:
PDF, 573 KB
english, 2017